Colonization with antibiotic-susceptible strains protects against methicillin-resistant Staphylococcus aureus but not vancomycin-resistant enterococci acquisition: A nested case-control study

Critical Care

Volumn 15, Issue 5, 2011, Pages

  Huang, Susan S ^a,b   Datta, Rupak ^a,c   Rifas Shiman, Sheryl ^c   Kleinman, Ken ^c   Placzek, Hilary ^c,d   Lankiewicz, Julie D ^c   Platt, Richard ^b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIINFECTIVE AGENT;

ADULT; AGED; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIUM CULTURE; CASE CONTROL STUDY; COMORBIDITY; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HUMAN; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; NOSE SMEAR; PREDICTION; PRIORITY JOURNAL; SCREENING; VANCOMYCIN RESISTANT ENTEROCOCCUS; ANTIBIOTIC RESISTANCE; CROSS INFECTION; DRUG EFFECT; ENTEROCOCCUS; INTENSIVE CARE UNIT; MIDDLE AGED; PENICILLIN RESISTANCE; RETROSPECTIVE STUDY; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION;

ADULT; AGED; ANTI-BACTERIAL AGENTS; CASE-CONTROL STUDIES; CROSS INFECTION; ENTEROCOCCUS; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; METHICILLIN RESISTANCE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; VANCOMYCIN RESISTANCE;

EID: 80052651864     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10445     Document Type: Article

References (61)

1. Klein E, Smith DL, Laxminarayan R. Hospitalizations and deaths caused by MRSA, United States, 1999-2005. Emerg Infect Dis 2007, 13:1840-1846. 2876761, 18258033.
2. Cosgrove SE, Sakoulas G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y. Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 2003, 36:53-59. 10.1086/345476, 12491202.
3. Cosgrove SE, Qi Y, Kaye KS, Harbarth S, Karchmer AW, Carmeli Y. The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol 2005, 26:166-174. 10.1086/502522, 15756888.
4. National Nosocomial Infections Surveillance System National Nosocomial Infections Surveillance (NNIS) System Report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004, 32:470-485. 10.1016/j.ajic.2004.10.001, 15573054, National Nosocomial Infections Surveillance System.
5. Patel R. Clinical impact of vancomycin-resistant enterococci. J Antimicrob Chemother 2003, 51:iii13-iii21.
6. Pelz RK, Lipsett PA, Swoboda SM, Diener-West M, Powe NR, Brower RG, Perl TM, Hammond JM, Hendrix CW. Vancomycin-sensitive and vancomycin-resistant enterococcal infections in the ICU: attributable costs and outcomes. Intensive Care Med 2002, 28:692-697. 10.1007/s00134-002-1276-8, 12107672.
7. Asensio A, Guerrero A, Quereda C, Lizán M, Martinez-Ferrer M. Colonization and infection with methicillin-resistant Staphylococcus aureus: associated factors and eradication. Infect Control Hosp Epidemiol 1996, 17:20-28. 10.1086/647184, 8789683.
8. Coello R, Glynn JR, Gaspar C, Pacazo JJ, Fereres J. Risk factors for developing clinical infection with methicillin-resistant Staphylococcus aureus (MRSA) amongst hospital patients initially only colonized with MRSA. J Hosp Infect 1997, 37:39-46. 10.1016/S0195-6701(97)90071-2, 9321727.
9. Pujol M, Pena C, Pallares R, Ayats J, Ariza J, Gudiol F. Risk factors for nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Eur J Clin Microbiol Infect Dis 1994, 13:96-102. 10.1007/BF02026134, 8168571.
10. Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, Farr BM, . SHEA SHEA guideline for preventing nosocomial transmission of multidrug-resistant strains of Staphylococcus aureus and enterococcus. Infect Control Hosp Epidemiol 2003, 24:362-386. 10.1086/502213, 12785411, SHEA.
11. Matar MJ, Tarrand J, Raad I, Rolston KVI. Colonization and infection with vancomycin-resistant Enterococcus among patients with cancer. Am J Infect Control 2006, 34:534-536. 10.1016/j.ajic.2006.04.205, 17015161.
12. McNeil SA, Malani PN, Chenoweth CE, Fontana RJ, Magee JC, Punch JD, Mackin ML, Kauffman CA. Vancomycin-resistant enterococcal colonization and infection in liver transplant candidates and recipients: a prospective surveillance study. Clin Infect Dis 2006, 42:195-203. 10.1086/498903, 16355329, 16355329.
13. Huang SS, Platt R. Risk of methicillin-resistant Staphylococcus aureus infection after previous infection or colonization. Clin Infect Dis 2003, 36:281-285. 10.1086/345955, 12539068.
14. Datta R, Huang SS. Risk of postdischarge infection with vancomycin-resistant enterococcus after initial infection or colonization. Infect Control Hosp Epidemiol 2010, 31:1290-1293. 10.1086/657332, 3075426, 20979493.
15. Datta R, Huang SS. Risk of infection and death due to methicillin-resistant Staphylococcus aureus in long-term carriers. Clin Infect Dis 2008, 47:176-181. 10.1086/589241, 2649874, 18532892.
16. Safdar N, Bradley EA. The risk of infection after nasal colonization with Staphylococcus aureus. Am J Med 2008, 121:310-315. 10.1016/j.amjmed.2007.07.034, 18374690.
17. Honda H, Krauss MJ, Coopersmith CM, Kollef MH, Richmond AM, Fraser VJ, Warren DK. Staphylococcus aureus nasal colonization and subsequent infection in intensive care unit patients: does methicillin-resistance matter?. Infect Control Hosp Epidemiol 2010, 31:584-591. 10.1086/652530, 20426656.
18. Blot SI, Vandewoude KH, Hoste EA, Colardyn FA. Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med 2002, 162:2229-2235. 10.1001/archinte.162.19.2229, 12390067.
19. Wolkewitz M, Frank U, Philips G, Schumacher M, Davey P. Mortality associated with in-hospital bacteraemia caused by Staphylococcus aureus: a multistate analysis with follow-up beyond hospital discharge. J Antimicrob Chemother 2011, 66:381-386. 10.1093/jac/dkq424, 21098543.
20. Gorwitz RJ, Kruszon-Moran D, McAllister SK, McQuillan G, McDougal LK, Fosheim GE, Jensen BJ, Killgore G, Tenover FC, Kuehnert MJ. Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004. J Infect Dis 2008, 197:1226-1234. 10.1086/533494, 18422434, 18422434 .
21. Salangsang JA, Harrison LH, Brooks MM, Shutt KA, Saul MI, Muto CA. Patient-associated risk factors for acquisition of methicillin-resistant Staphylococcus aureus in a tertiary care hospital. Infect Control Hosp Epidemiol 2010, 31:1139-1147. 10.1086/656595, 20923281.
22. Warren DK, Guth RM, Coopersmith CG, Merz LR, Zack JE, Fraser VJ. Epidemiology of methicillin-resistant Staphylococcus aureus colonization in a surgical intensive care unit. Infect Control Hosp Epidemiol 2006, 27:1032-1040. 10.1086/507919, 17006809.
23. Marshall C, Harrington G, Wolfe R, Fairley CK, Wesselingh S, Spelman D. Acquisition of methicillin-resistant Staphylococcus aureus in a large intensive care unit. Infect Control Hosp Epidemiol 2003, 24:322-326. 10.1086/502215, 12785404.
24. Huang SS, Rifas-Shiman SL, Warren DK, Fraser VJ, Climo MW, Wong ES, Cosgrove SE, Perl TM, Pottinger JM, Herwaldt LA, Jernigan JA, Tokars JL, Diekema DJ, Hinrichsen VL, Yokoe DS, Platt R, . Centers for Disease Control and Prevention Epicenters Program Improving methicillin-resistant Staphylococcus aureus surveillance and reporting in intensive care units. J Infect Dis 2007, 195:330-338. 10.1086/510622, 17205470, Centers for Disease Control and Prevention Epicenters Program.
25. Aizen E, Ljubuncic Z, Ljubuncic P, Aizen I, Potasman I. Risk factors for methicillin-resistant Staphylococcus aureus colonization in a geriatric rehabilitation hospital. J Gerontol A Biol Sci Med Sci 2007, 62:1152-1156.
26. Robiczek A, Beaumont JL, Thomson RB, Govindarajan G, Peterson LG. Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk. Infect Control Hosp Epidemiol 2009, 30:623-632. 10.1086/597550, 19496730.
27. Hayden M. Insights into the epidemiology and control of infection with vancomycin-resistant enterococci. Clin Infect Dis 2000, 31:1058-1065. 10.1086/318126, 11049790.
28. Bhorade SM, Christenson J, Pohlman AS, Arnow PM, Hall JB. The incidence of and clinical variables associated with vancomycin-resistant enterococcal colonization in mechanically ventilated patients. Chest 1999, 115:1085-1091. 10.1378/chest.115.4.1085, 10208212.
29. Beltrami EM, Singer DA, Fish L, Manning K, Young S, Banerjee SN, Baker R, Jarvis WR. Risk factors for acquisition of vancomycin-resistant enterococci among patients on a renal ward during a community hospital outbreak. Am J Infect Control 2000, 28:282-285. 10.1067/mic.2000.106276, 10926704.
30. Ostrowsky BE, Venkataraman L, D'Agata EM, Gold HS, DeGirolami PC, Samore MH. Vancomycin-resistant enterococci in intensive care units. Arch Intern Med 1999, 159:1467-1472. 10.1001/archinte.159.13.1467, 10399898.
31. Suntharam N, Lankford MG, Trick WE, Peterson LR, Noskin GA. Risk factors for acquisition of vancomycin-resistant enterococci among hematology-oncology patients. Diagn Microbiol Infect Dis 2002, 43:183-188. 10.1016/S0732-8893(02)00392-9, 12106950.
32. Carmeli Y, Eliopoulos GM, Samore MH. Antecedent treatment with different antibiotic agents as a risk factor for vancomycin-resistant Enterococcus. Emerg Infect Dis 2002, 8:802-807. 2732508, 12141965.
33. Hardy KJ, Oppenheim BA, Gossain S, Gao F, Hawkey PM. A study of the relationship between environmental contamination with methicillin-resistant Staphylococcus aureus (MRSA) and patients' acquisition of MRSA. Infect Control Hosp Epidemiol 2006, 27:127-132. 10.1086/500622, 16465628.
34. Drees M, Snydman DR, Schmid CH, Barefoot L, Hansjosten K, Vue PM, Cronin M, Nasraway SA, Golan Y. Prior environmental contamination increases the risk of acquisition of vancomycin-resistant enterococci. Clin Infect Dis 2008, 46:678-685. 10.1086/527394, 18230044.
35. Huang SS, Datta R, Platt R. Risk of acquiring antibiotic-resistant bacteria from prior room occupants. Arch Intern Med 2006, 166:1945-1951. 10.1001/archinte.166.18.1945, 17030826.
36. Boyce JM, Potter-Bynoe G, Chenevert C, King T. Environmental contamination due to methicillin-resistant Staphylococcus aureus: possible infection control implications. Infect Control Hosp Epidemiol 1997, 18:622-627. 10.1086/647686, 9309433.
37. Bhalla A, Pultz NJ, Gries DM, Ray AJ, Eckstein EC, Aron DC, Donskey CJ. Acquisition of nosocomial pathogens on hands after contact with environmental surfaces near hospitalized patients. Infect Control Hosp Epidemiol 2004, 25:164-167. 10.1086/502369, 14994944.
38. Hayden MK, Blom DW, Lyle EA, Moore CG, Weinstein RA. Risk of hand or glove contamination after contact with patients colonized with vancomycin-resistant enterococcus or the colonized patients' environment. Infect Control Hosp Epidemiol 2008, 29:149-154. 10.1086/524331, 18179370.
39. Martinez JA, Ruthazer R, Hansjosten K, Barefoot L, Snydman DR. Role of environemental contamination as a risk factor for acquisition of vancomycin-resistant enterococci in patients treated in a medical intensive care unit. Arch Intern Med 2003, 163:1905-1912. 10.1001/archinte.163.16.1905, 12963563.
40. Dall'Antonia M, Coen PG, Wilks M, Whiley A, Millar M. Competition between methicillin-sensitive and -resistant Staphylococcus aureus in the anterior nares. J Hosp Infect 2005, 61:62-67. 10.1016/j.jhin.2005.01.008, 15893854.
41. Lauplan KB, Ross T, Gregson DB. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006. J Infect Dis 2008, 198:336-343. 10.1086/589717, 18522502.
42. Kang CI, Song JH, Chung DR, Peck KR, Ko KS, Yeom JS, Kim SW, Chang HH, Kim YS, Jung SI, Son JS, Hsueh PR, So TM, Lalitha MK, Yang Y, Huang SG, Wang H, Lu Q, Carlos CC, Perera JA, Chiu CH, Liu JW, Chongthaleong A, Thamlikitkul V, Van Pham H, . Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study Group Clinical impact of methicillin resistance on outcome of patients with Staphylococcus aureus infection: a stratified analysis according to underlying diseases and sites of infection in a large prospective cohort. J Infect 2010, 61:299-366. 10.1016/j.jinf.2010.07.011, 20670652, Asian Network for Surveillance of Resistant Pathogens (ANSORP) Study Group.
43. Perl TM, Cullen JJ, Wenzel RP, Zimmerman MB, Pfaller MA, Sheppard D, Twombley J, French PP, Herwaldt LA. Intranasal mupirocin to prevent postoperative Staphylococcus aureus infections. N Engl J Med 2002, 346:1871-1877. 10.1056/NEJMoa003069, 12063371.
44. Engleman R, Shahian D, Shemin R, Guy TS, Bratzler D, Edwards F, Jacobs M, Fernando H, Bridges C. The Society of Thoracic Surgeons practice guidelines series: antibiotic prophylaxis in cardiac surgery, Part II: antibiotic choice. Ann Thorac Surg 2007, 83:1569-1576. 10.1016/j.athoracsur.2006.09.046, 17383396.
45. Kallen AJ, Wilson CT, Larson RJ. Perioperative intranasal mupirocin for the prevention of surgical-site infections: systematic review of the literature and meta-analysis. Infect Control Hosp Epidemiol 2005, 26:916-922. 10.1086/505453, 16417031.
46. Ridenour G, Lampen R, Fiderspiel J, Kritchevsky S, Wong E, Climo M. Use of intranasal mupirocin and chlorhexidine bathing and the incidence of methicillin-resistant Staphylococcus aureus colonization and infection among intensive care units patients. Infect Control Hosp Epidemiol 2007, 28:1155-1161. 10.1086/520102, 17828692.
47. Simor AE, Phillips E, McGeer A. Randomized controlled trial of chlorhexidine gluconate for washing, intranasal mupirocin, and rifampin and doxycycline versus no treatment for the eradication of methicillin-resistant Staphylococcus aureus colonization. Clin Infect Dis 2007, 44:178-185. 10.1086/510392, 17173213.
48. Climo MW, Sepkowitz KA, Zuccotti G, Fraser VJ, Warren DK, Perl TM, Speck K, Jernigan JA, Robles JR, Wong ES. The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial. Crit Care Med 2009, 37:1858-1865. 10.1097/CCM.0b013e31819ffe6d, 19384220.
49. Robicsek A, Beaumont JL, Thomson RB, Govindarajan G, Peterson LR. Topical therapy for methicillin-resistant Staphylococcus aureus colonization: impact on infection risk. Infect Control Hosp Epidemiol 2009, 30:623-632. 10.1086/597550, 19496730.
50. Bode LG, Kluytmans JA, Wertheim HF, Bogaers D, Vandenbroucke-Grauls CM, Roosendaal R, Troelstra A, Box AT, Voss A, van der Tweel I, van Belkum A, Verbrugh HA, Vos MC. Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med 2010, 362:9-17. 10.1056/NEJMoa0808939, 20054045.
51. van Rijen M, Bonten M, Wenzel R, Kluytmans J. Mupirocin ointment for preventing Staphylococcus aureus infections in nasal carriers. Cochrane Database Syst Rev 2008, 4:CD006216.
52. Edgeworth JD. Has decolonization played a central role in the decline in UK methicillin resistant Staphylococcus aureus transmission? A focus on evidence from intensive care. J Antimicrob Chemother 2011, 66:ii41-47. 10.1093/jac/dkq325, 20852273.
53. Fraser TG, Fatica C, Scarpelli M, Arroliga AC, Guzman J, Shrestha NK, Hixson E, Rosenblatt M, Gordon SM, Procop GW. Decrease in Staphylococcus aureus colonization and hospital-acquired infection in a medical intensive care unit after institution of an active surveillance and decolonization program. Infect Control Hosp Epidemiol 2010, 31:779-783. 10.1086/654001, 20594110.
54. Reed SD, Friedman JY, Engemann JJ, Griffiths RI, Anstrom KJ, Kaye KS, Stryjewski ME, Szczech LA, Reller LB, Corey GR, Schulman KA, Fowler VG. Costs and outcomes among hemodialysis patients with methicillin-resistant or methicillin-susceptible Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 2005, 26:175-183. 10.1086/502523, 15756889.
55. Song X, Srinivasan A, Plaut D, Perl TM. Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay and costs. Infect Control Hosp Epidemiol 2003, 24:251-256. 10.1086/502196, 12725353.
56. Nseir S, Di Pompeo C, Soubrier S, Delour P, Lench H, Roussel-Delvallez M, Onimus T, Saulnier F, Mathieu D, Durocher A. First-generation fluoroquinolone use and subsequent emergence of multiple drug-resistant bacteria in the intensive care unit. Crit Care Med 2005, 33:283-289. 10.1097/01.CCM.0000152230.53473.A1, 15699829.
57. Weber SG, Gold HS, Hooper DC, Karchmer AW, Carmeli Y. Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients. Emerg Infect Dis 2003, 9:1415-1422. 3035560, 14718085.
58. Tacconelli E, De Angelis G, Cataldo MA, Pozzi E, Cauda R. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. J Antimicrob Chemother 2008, 61:26-38.
59. DeLisle S, Perl TM. Vancomycin-resistant enterococci: a road map on how to prevent the emergence and transmission of antimicrobial resistance. Chest 2003, 123:504S-518S. 10.1378/chest.123.5_suppl.504S, 12740236.
60. Zhou Q, Moore C, Eden S, Tong A, McGeer A. Factors associated with acquisition of vancomycin-resistant enterococci (VRE) in roommate contacts of patients colonized or infected with VRE in a tertiary care hospital. Infect Control Hosp Epidemiol 2008, 29:398-403. 10.1086/587187, 18419360.
61. Shurland SM, Stine OC, Venezia RA, Johnson JK, Zhan M, Furuno JP, Miller RR, Johnson T, Roghmann MC. Colonization sites of USA300 methicillin-resistant Staphylococcus aureus in residents of extended care facilities. Infect Control Hosp Epidemiol 2009, 30:313-318. 10.1086/596114, 2852096, 19239380.